Return On Equity of Evoke Pharma Inc from 30 Jun 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Evoke Pharma Inc quarterly and annual Return On Equity in % history and change rate from 30 Jun 2014 to 30 Sep 2025.
  • Evoke Pharma Inc Return On Equity for the quarter ending 30 Sep 2025 was -101%, a 69% increase year-over-year.
  • Evoke Pharma Inc annual Return On Equity for 2024 was -122%, a 103% decline from 2023.
  • Evoke Pharma Inc annual Return On Equity for 2023 was 3952%.
  • Evoke Pharma Inc annual Return On Equity for 2022 was -114%, a 26% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Evoke Pharma Inc Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -101% +222% +69% 01 Jul 2025 30 Sep 2025
Q2 2025 -99% +907% +90% 01 Apr 2025 30 Jun 2025
Q1 2025 -102% +4796% +98% 01 Jan 2025 31 Mar 2025
Q4 2024 -122% -4073% -103% 01 Oct 2024 31 Dec 2024
Q3 2024 -323% -20% -6.7% 01 Jul 2024 30 Sep 2024
Q2 2024 -1007% -851% -548% 01 Apr 2024 30 Jun 2024
Q1 2024 -4898% -4783% -4176% 01 Jan 2024 31 Mar 2024
Q4 2023 3952% +4066% 01 Oct 2023 31 Dec 2023
Q3 2023 -303% -125% -70% 01 Jul 2023 30 Sep 2023
Q2 2023 -155% +29% +16% 01 Apr 2023 30 Jun 2023
Q1 2023 -115% +85% +43% 01 Jan 2023 31 Mar 2023
Q4 2022 -114% +40% +26% 01 Oct 2022 31 Dec 2022
Q3 2022 -178% +60% +25% 01 Jul 2022 30 Sep 2022
Q2 2022 -184% +246% +57% 01 Apr 2022 30 Jun 2022
Q1 2022 -200% +2230% +92% 01 Jan 2022 31 Mar 2022
Q4 2021 -155% -2186% -108% 01 Oct 2021 31 Dec 2021
Q3 2021 -238% +745% +76% 01 Jul 2021 30 Sep 2021
Q2 2021 -430% -40% -10% 01 Apr 2021 30 Jun 2021
Q1 2021 -2430% -2282% -1545% 01 Jan 2021 31 Mar 2021
Q4 2020 2032% +2182% 01 Oct 2020 31 Dec 2020
Q3 2020 -983% -823% -513% 01 Jul 2020 30 Sep 2020
Q2 2020 -390% -234% -150% 01 Apr 2020 30 Jun 2020
Q1 2020 -148% +21% +13% 01 Jan 2020 31 Mar 2020
Q4 2019 -150% +8% +4.8% 01 Oct 2019 31 Dec 2019
Q3 2019 -160% -19% -14% 01 Jul 2019 30 Sep 2019
Q2 2019 -156% +125% +45% 01 Apr 2019 30 Jun 2019
Q1 2019 -169% +69% +29% 01 Jan 2019 31 Mar 2019
Q4 2018 -158% +101% +39% 01 Oct 2018 31 Dec 2018
Q3 2018 -141% +121% +46% 01 Jul 2018 30 Sep 2018
Q2 2018 -282% -88% -45% 01 Apr 2018 30 Jun 2018
Q1 2018 -238% +99% +29% 01 Jan 2018 31 Mar 2018
Q4 2017 -258% +298% +54% 01 Oct 2017 31 Dec 2017
Q3 2017 -262% +379% +59% 01 Jul 2017 30 Sep 2017
Q2 2017 -194% +384% +66% 01 Apr 2017 30 Jun 2017
Q1 2017 -338% +4% +1.2% 01 Jan 2017 31 Mar 2017
Q4 2016 -557% -308% -124% 01 Oct 2016 31 Dec 2016
Q3 2016 -640% -444% -225% 01 Jul 2016 30 Sep 2016
Q2 2016 -578% -407% -238% 01 Apr 2016 30 Jun 2016
Q1 2016 -342% -212% -163% 01 Jan 2016 31 Mar 2016
Q4 2015 -248% -151% -155% 01 Oct 2015 31 Dec 2015
Q3 2015 -197% -125% -174% 01 Jul 2015 30 Sep 2015
Q2 2015 -171% -124% -267% 01 Apr 2015 30 Jun 2015
Q1 2015 -130% 01 Jan 2015 31 Mar 2015
Q4 2014 -97% 01 Oct 2014 31 Dec 2014
Q3 2014 -72% 01 Jul 2014 30 Sep 2014
Q2 2014 -47% 01 Apr 2014 30 Jun 2014

Evoke Pharma Inc Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -122% -4073% -103% 01 Jan 2024 31 Dec 2024
2023 3952% +4066% 01 Jan 2023 31 Dec 2023
2022 -114% +40% +26% 01 Jan 2022 31 Dec 2022
2021 -155% -2186% -108% 01 Jan 2021 31 Dec 2021
2020 2032% +2182% 01 Jan 2020 31 Dec 2020
2019 -150% +8% +4.8% 01 Jan 2019 31 Dec 2019
2018 -158% +101% +39% 01 Jan 2018 31 Dec 2018
2017 -258% +298% +54% 01 Jan 2017 31 Dec 2017
2016 -557% -308% -124% 01 Jan 2016 31 Dec 2016
2015 -248% -151% -155% 01 Jan 2015 31 Dec 2015
2014 -97% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.